Skip to main content
Skip to section navigation
Skip to footer
Back to Superleague.com
Investor Relations
Investors
Overview
News & Events
Overview
Press Releases
Media
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Quarterly Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
Analyst Coverage
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
All SEC Filings
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Filing Type:
View All
10-K
10-K/A
10-Q
3
4
424B3
424B4
424B5
8-A12B
8-K
8-K/A
AW
CERT
CORRESP
CT ORDER
D
D/A
DEF 14A
DEF 14C
DEFA14A
DEFR14C
DRS
DRS/A
DRSLTR
EFFECT
FWP
NT 10-K
NT 10-Q
POS AM
PRE 14A
PRE 14C
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SEC STAFF LETTER
UPLOAD
Year:
View All
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015
2014
Date
Form
Description
PDF
XBRL
Pages
03/21/24
UPLOAD
SEC-generated letter
Documents
TEXT-EXTRACT
1
03/21/24
4
Statement of changes in beneficial ownership of securities
1
03/21/24
4
Statement of changes in beneficial ownership of securities
1
03/21/24
4
Statement of changes in beneficial ownership of securities
1
03/15/24
S-3
Registration statement for specified transactions by certain issuers
Documents
EX-3.10
EX-FILING FEES
88
03/15/24
8-K
Current report filing
Documents
EX-10.1
6
03/01/24
8-K
Current report filing
Documents
EX-99.1
5
01/05/24
D/A
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
12/22/23
8-K
Current report filing
Documents
EX-3.1
EX-10.1
EX-10.2
79
12/11/23
D
Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.
5
Previous
1
2
3
4
5
6
7
8
9
10
Next
Email Alerts
Tear Sheet
Contacts
RSS News Feed
CONTACT PRESS